Diabetes Drug Avandia Under SiegeMonday, February 22, 2010
Diabetes Drug Avandia Under Siege
By Mike Boyle
The widely used type 2 diabetes drug Avandia is being linked with tens of thousands of heart attacks, and it is alleged that its maker, GlaxoSmithKline, knew of the risks for years but worked to keep them from the public, according to a staff report from the Senate Committee on Finance released on February 20.
The 334-page report also criticizes the Food and Drug Administration, saying that the federal agency that regulates food, tobacco and medications overlooked or overrode safety concerns found by its staff.
Meanwhile, GlaxoSmithKline says the Senate committee report “draws conclusions on the safety of Avandia (rosiglitazone maleate) that are based on analyses that are not consistent with the rigorous scientific evidence supporting the safety of the drug.”
Originally posted February 22, 2010.